# FDA 483 - Ballard Plaza Pharmacy I, Inc. - May 17, 2016

Source: https://www.keypedia.com/records/483/ballard-plaza-pharmacy-i-inc/28923ccf-e9a2-4be1-84a9-3464a64db16e

> FDA 483 for Ballard Plaza Pharmacy I, Inc. on May 17, 2016. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ballard Plaza Pharmacy I, Inc.
- Inspection Date: 2016-05-17
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: This FDA Form 483, issued on May 17, 2016, to William G. Ewing, RPh, Owner of Ballard Plaza Pharmacy I, Inc. (FEI 3006317860) in Seattle, WA, details observations from an inspection conducted from April 25-28, May 2-3, and May 17, 2016. The firm is identified as a producer of sterile drug products.

**Key Observations:**

1.  **Deficient Aseptic Processing Areas (Cleaning/Disinfection):**
    *   A detached wood panel exposing uncleanable fibrous material in the laminar flow hood (LFH).
    *   Use of non-sterile wipes for cleaning ISO 5 LFH, ISO 7 clean room, and ISO 8 anteroom surfaces.
    *   Apparent soiled material on the LFH pre-filter grate.
    *   Rust on a mobile cart in the ISO 7 clean room.
    *   Soiled telephone handset in the ISO 7 clean room.
    *   Residue on classified area sides of glass windows.
    *   An eight-inch crack on a glass window between the ISO 8 anteroom and ISO 7 clean room.

2.  **Inadequate Sterilization Process Validation:**
    *   No bioburden limits established for sterilization processes.

## Related Documents

- [483 - 2016-05-17](https://www.keypedia.com/records/483/ballard-plaza-pharmacy-i-inc/d837b5b1-a350-43d4-9ad7-327035d1b0c4)
- [WARNING_LETTER - 2016-05-17](https://www.keypedia.com/records/warning_letter/ballard-plaza-pharmacy-i-inc/fb42fd2a-e988-4c6d-b085-29c42a10b101)

## Related Officers

- [Registered Nurse](https://www.keypedia.com/people/gerard-de-leon/1c84d3b7-b56f-4c97-aa3f-a96862c348cd)
- [Gary C. Pecic](https://www.keypedia.com/people/gary-c-pecic/37cf1f4d-6b1c-4be6-8adb-89cf685f5022)
- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [Division Director at CDRH/OPEQ/Office of Regulatory Programs](https://www.keypedia.com/people/lisa-t-michel/b14c9205-185f-4eaa-bf3c-3bf5bbc50a06)

Company: https://www.keypedia.com/companies/ballard-plaza-pharmacy-i-inc/e3c1298d-cfd5-4742-b6c0-43cc5bc0bdc7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c